HOXD13
Homeobox protein Hox-D13
Also known as: HOX4I, HXD13_HUMAN, SPD
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35453
- Gene
- HOXD13
- Ensembl
- ENSG00000128714
- Chromosome
- 2
- Canonical length
- 343 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene belongs to the homeobox family of genes. The homeobox genes encode a highly conserved family of transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar homeobox gene clusters, HOXA, HOXB, HOXC and HOXD, located on different chromosomes, consisting of 9 to 11 genes arranged in tandem. This gene is one of several homeobox HOXD genes located in a cluster on chromosome 2. Deletions that remove the entire HOXD gene cluster or the 5' end of this cluster have been associated with severe limb and genital abnormalities. Mutations in this particular gene cause synpolydactyly. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
343 residues, UniProt reviewed canonical sequence.
>P35453|HOXD13
1 MSRAGSWDMD GLRADGGGAG GAPASSSSSS VAAAAASGQC RGFLSAPVFA GTHSGRAAAA
61 AAAAAAAAAA ASGFAYPGTS ERTGSSSSSS SSAVVAARPE APPAKECPAP TPAAAAAAPP
121 SAPALGYGYH FGNGYYSCRM SHGVGLQQNA LKSSPHASLG GFPVEKYMDV SGLASSSVPA
181 NEVPARAKEV SFYQGYTSPY QHVPGYIDMV STFGSGEPRH EAYISMEGYQ SWTLANGWNS
241 QVYCTKDQPQ GSHFWKSSFP GDVALNQPDM CVYRRGRKKR VPYTKLQLKE LENEYAINKF
301 INKDKRRRIS AATNLSERQV TIWFQNRRVK DKKIVSKLKD TVSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HOXD13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- colon: 16 nTPM
- seminal vesicle: 15 nTPM
- vagina: 15 nTPM
- cervix: 12 nTPM
- prostate: 9 nTPM
- rectum: 7.2 nTPM
Single-cell type
- basal prostatic cells: 18 nCPM
- prostatic club cells: 17 nCPM
- colonocytes: 11 nCPM
- enteric transient amplifying cells: 10 nCPM
- goblet cells: 9.5 nCPM
- prostatic hillock cells: 8.5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 0.3 nTPM
- pons: 0.3 nTPM
- medulla oblongata: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebral cortex: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HOXD13.
Disease | AllUniProt
Conditions HOXD13 is implicated in, by any mechanism.
- Synpolydactyly 1 (SPD1) MIM:186000
- Brachydactyly D (BDD) MIM:113200
- Syndactyly 5 (SDTY5) MIM:186300
- Brachydactyly-syndactyly syndrome (BDSD) MIM:610713
- Brachydactyly E1 (BDE1) MIM:113300
- VACTERL association (VACTERL) MIM:192350
- Brachydactyly-syndactyly-oligodactyly syndrome (BDSDO) MIM:610713
Disease | GeneticClinVar
34 pathogenic / likely-pathogenic of 190 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Synpolydactyly type 1
- Syndactyly type 5
- HOXD13-related disorder
- Brachydactyly type D
- Brachydactyly-syndactyly syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.04
- DepMap mean gene effect
- -0.27
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterior/posterior pattern specification
- embryonic digit morphogenesis
- embryonic hindgut morphogenesis
- male genitalia development
- morphogenesis of an epithelial fold
- positive regulation of transcription by RNA polymerase II
- prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis
- regulation of branching involved in prostate gland morphogenesis
- regulation of cell population proliferation
- regulation of DNA-templated transcription
- regulation of transcription by RNA polymerase II
- response to testosterone
- skeletal system development
- transcription by RNA polymerase II
- branch elongation of an epithelium
Molecular functions
- chromatin binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HOXD13 as an antibody target. Whether an autoantibody or antibody against HOXD13 could matter depends on whether native HOXD13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HOXD13 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HOXD13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...